 DEVON, Pa., April 05, 2022 GLOBE NEWSWIRE -- Zynerba Pharmaceuticals, Inc. Nasdaq: ZYNE, the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Armando Anido, Chief Executive Officer of Zynerba, will present a company overview during the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11, 2022, at 12:45 p.m. ET. 